We’re presenting preclinical data at #AACR26 on the potential of our CCNE1-directed molecular glue degrader to treat CCNE1-amplified solid tumors, suggesting a potential new approach to a historically undruggable target.

Learn more:
https://
bit.ly/48M39g3